We reviewed our experience with the management of men 70 to 79 years old with clinically
localized prostate cancer to determine whether surgical candidates were likely to die of …

A total of 61 patients, less than 70 years old at diagnosis, with clinical stage T1-2, NX, M0,
cytologically well or moderately differentiated prostate adenocarcinoma was prospectively …

ContextThe appropriate therapy for men with clinically localized prostate cancer is uncertain.
A recent study suggested an increasing prostate cancer mortality rate for men who are alive …

Background The selection of treatment for patients with localized prostate cancer requires
reliable information about the outcome of conservative management. Previous studies of this …

Abstract From 1966 to 1979, 360 patients with clinical stages A2, B and Cl prostate cancer
underwent staging pelvic lymphadenectomy, and completed a course of combined …

PURPOSE: We investigated the long-term outcome of prostate cancer. MATERIALS AND
METHODS: Causes of death were examined in 490 patients diagnosed with prostate cancer …

OBJECTIVES: To report the long-term survival probability in more than 3000 men with
localized prostate cancer treated either conservatively or by definitive treatment …

Objectives. To study the long-term survival of patients with prostate cancer, determine the
risk factors for prostate cancer death, and investigate the outcome of initially untreated …

The natural history of prostate cancer has long been regarded as unpredictable. The
discrepancy between histologically identifiable (40%) and clinically diagnosed carcinomas …

Objective.—To determine age-specific, all-cause mortality, disease-specific mortality, and
life expectancy for men aged 65 to 75 years who are treated only with immediate or delayed …